Ra Pharmaceuticals
Cambridge, US · Founded 1928 · Delaware corporation · 15,154 employees on LinkedIn · 3 known investors
Founders & leadership
Ra Pharmaceuticals was founded in 1928 by Douglas A. Treco.
DA
KB
Kerry BlackExecutive
Board
EM
Edward MathersBoard director
RS
PB
Peter BisgaardBoard director
JL
Jason LettmanBoard director
MG
Markus GoebelBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$29.2M disclosed across 1 round · 2015
▶$29.2MraisedJul 2015 · 11 investors · PharmaceuticalsRule 506(b)
▶$29.2MraisedJul 2015 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Douglas A. TrecoExecutive Officer, Director
- Edward MathersDirector
- Rajeev ShahDirector
- Peter BisgaardDirector
- Jason LettmanDirector
- Kerry BlackExecutive Officer
- Markus GoebelDirector
- Offering amount
- $58.5M
- Amount sold
- $29.2M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Ra Pharmaceuticals?
- Ra Pharmaceuticals was founded by Douglas A. Treco in 1928.
- Who are Ra Pharmaceuticals's investors?
- Ra Pharmaceuticals's investors include Lightstone Ventures, New Enterprise Associates (NEA), RA Capital.
- How much funding has Ra Pharmaceuticals raised?
- Ra Pharmaceuticals has disclosed $29.2M raised across 1 round.
- Where is Ra Pharmaceuticals headquartered?
- Ra Pharmaceuticals is headquartered in Cambridge, US.